title: How I treat ovarian cancer in older women.
abstract: Advancing age in patients with epithelial ovarian cancer is a risk factor for decreased survival. The exact cause is unknown but part of this may be due to less than adequate therapy for these patients. To optimize treatment, this paper presents the available data for therapy and my own approach in the management of this disease. For optimal outcomes, there also needs to be a close collaboration between subspecialists (gynecologic oncology, medical oncology, pathology) in all aspects of treatment planning. Progression-free and overall survival can be prolonged and patients' quality of life can be maintained with appropriate management.
authors: 65+ Clinical Geriatrics Program, Gynecologic Oncology Disease Management Team, Memorial Sloan Kettering Cancer Center, Commack, NY, United States. Electronic address: lichtmas@mskcc.org.
authors: Stuart M
authors: SM
authors: Lichtman
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000077216:Carcinoma, Ovarian Epithelial; D003131:Combined Modality Therapy; D065426:Cytoreduction Surgical Procedures / Q000379:methods; D019008:Drug Resistance, Neoplasm; D005260:Female; D005544:Forecasting; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D009375:Neoplasms, Glandular and Epithelial / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000628:therapy*; D011788:Quality of Life; D012086:Reoperation
keywords: Carboplatin; Cisplatin; Elderly; Intraperitoneal; Ovarian cancer; Paclitaxel; Serous ovarian cancer